샘플 요청 목록

 카트 문의
시장보고서
상품코드
1836260

뇌졸중 재활 시장 : 치료 유형별, 제품 유형별, 뇌졸중 유형별, 최종 이용 업계별, 국가별, 지역별 - 세계 산업 분석, 시장 규모, 시장 점유율, 예측(2025-2032년)

Stroke Rehabilitation Market, By Treatment Type, By Product Type, By Stroke Type, By End-user Verticals, By Country, and By Region - Global Industry Analysis, Market Size, Market Share & Forecast from 2025-2032
발행일: | 리서치사: AnalystView Market Insights | 페이지 정보: 영문 260 Pages | 배송안내 : 2-3일 (영업일 기준)

    
    
    




※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

뇌졸중 재활 시장 규모는 2024년 2억 8,939만 달러로 2025년부터 2032년까지 CAGR 11.60%로 성장할 것으로 예상됩니다.

재활은 질병이나 부상을 입은 환자의 회복과 정상적인 활동 재개를 돕는 서비스입니다. 뇌졸중 재활치료는 동작, 언어, 근력, 일상생활 동작 등 신체적, 정신적, 정서적 기능을 개선하여 독립성을 회복시켜 줍니다. 제공되는 치료 유형은 뇌의 환부에 따라 결정됩니다. 뇌졸중 재활에는 운동기술 훈련, 이동 훈련, 심리 평가 및 치료 등 다양한 접근법이 포함됩니다. 뇌졸중 재활 서비스는 입원, 외래, 숙련된 간호 시설, 재가 재활 등 다양한 환경에서 제공됩니다.

뇌졸중 재활 시장 - 시장 역학

만성질환의 증가로 뇌졸중 재활치료 시장 성장 촉진

만성질환의 유병률 증가가 뇌졸중 재활치료 시장을 견인할 것으로 예상됩니다. 만성질환은 1년 이상 지속되고 일상생활에 지장을 초래하기 때문에 지속적인 치료가 필요합니다. 뇌졸중 재활은 치료와 보조기구를 통해 표적화된 치료와 지원을 제공함으로써 심혈관질환 등 다양한 만성질환을 앓고 있는 환자들을 돕습니다. 예를 들어, 미국심장학회는 뇌졸중 환자 증가를 포함해 미국 내 심혈관질환률이 크게 증가할 것으로 예측하고 있습니다. 이러한 질환의 유병률 증가는 효과적인 뇌졸중 재활 서비스의 필요성을 강조하고 있으며, 환자의 예후와 삶의 질을 개선하는 치료법과 장비에 대한 수요 증가로 인해 시장 성장을 촉진하고 있습니다.

뇌졸중 재활 시장 - 세분화 분석:

뇌졸중 재활 세계 시장은 치료 유형, 제품 유형, 뇌졸중 유형, 최종사용자 산업별, 지역별로 분류됩니다.

시장은 뇌졸중 유형에 따라 허혈성 뇌졸중, 출혈성 뇌졸중, 일과성 뇌허혈 발작 등 3가지로 분류됩니다. 예측 기간 동안 뇌졸중 재활치료 시장은 출혈성 뇌졸중 분야에서 큰 성장이 예상됩니다. 출혈성 뇌졸중은 뇌혈관이 파열되어 출혈을 일으켜 발생합니다. 출혈성 뇌졸중 발병률의 증가와 연구개발 활동의 활성화가 이 부문의 성장을 주도하고 있습니다. 출혈성 뇌졸중 후 재활치료는 뇌 손상을 회복시키는 것은 아니지만, 장기적으로 최상의 결과를 얻을 수 있도록 도와줍니다. 한 연구에 따르면 허혈성 뇌졸중 후 재활치료가 출혈성 뇌졸중 후보다 출혈성 뇌졸중 후 재활치료가 더 효과적일 수 있는 것으로 나타났습니다. 그 결과, 보다 진보된 치료를 제공하기 위한 새로운 치료 전략이 개발되고 있습니다.

시장은 최종사용자 산업별로 병원, 외래 수술 센터, 장기 치료 센터, 전문 클리닉, 재택 요양 시설, 재활 센터, 기타 최종사용자 산업별 등 7가지 범주로 분류됩니다. 2025년에는 병원 부문이 세계 뇌졸중 재활치료 시장을 독점했습니다. 환자들이 뇌졸중 재활을 위해 병원을 선호하는 이유는 첨단 장비, 숙련된 전문가, 충분한 설비투자를 이용할 수 있기 때문입니다. 병원은 더 나은 환자 치료를 제공하기 위해 엄격한 규제 지침을 따르고 있습니다. 또한, 병원은 새로운 치료법의 안전성과 유효성을 평가하는 다양한 임상시험에 참여하고 있습니다. 이를 통해 환자들은 이러한 치료 요법의 혜택을 누릴 수 있습니다. 그 결과, 임상시험의 증가가 이 부문의 성장에 기여하고 있습니다. 2025년 1월 현재 clinicaltrials.gov에 등록된 뇌졸중 재활 중재에 관한 임상시험은 총 416건(활성, 비공모, 모집 중)입니다.

뇌졸중 재활치료 시장 - 지리적 인사이트

2025년 뇌졸중 재활치료 시장은 북미가 가장 큰 점유율을 차지했습니다. 뇌졸중 유병률 증가, 첨단 기술 채택 증가, 노인 인구 증가가 이 시장을 주도하고 있습니다. 미국에는 현재 65세 이상 노인이 6,200만 명으로 전체 인구의 18%를 차지하고 있습니다. 2054년에는 미국 전체 인구의 23%가 65세 이상이 될 것으로 예측됩니다. 캐나다에서는 약 100만 명이 뇌졸중을 앓고 있는 것으로 추정됩니다. 이 때문에 뇌졸중 재활치료에 대한 수요가 증가하고 있습니다. 정부와 민간단체의 투자 증가가 북미의 뇌졸중 재활을 뒷받침하고 있습니다.

예측 기간 동안 뇌졸중 재활치료 시장은 아시아태평양이 가장 빠른 속도로 성장할 것으로 예상됩니다. 이 시장은 뇌졸중 발병률 증가, 정부의 우호적인 정책, 투자 증가에 힘입어 성장하고 있습니다. 인지도 향상과 가처분 소득의 증가가 시장을 활성화시킵니다. 중국, 인도, 일본 등의 국가들이 아시아태평양의 뇌졸중 재활을 주도하고 있습니다.

뇌졸중 재활치료 시장 - 경쟁 상황:

뇌졸중 재활치료 시장에는 대기업, 대형 의료기기 기업, 재활전문센터, 소규모 신생 기술기업 등 다양한 경쟁 구도가 존재합니다. Penumbra, Inc.(REAL System), Shanghai Siyi Intelligent Technology Co., Ltd., DJO Global, Saebo Inc. 등 주요 기업들은 보조기구, 치료 기기, 소프트웨어 솔루션 등 다양한 재활 제품을 제공합니다. 보조기구, 치료 기기, 소프트웨어 솔루션 등 다양한 재활 제품을 제공하고 있습니다. 제품의 혁신성, 임상 결과, 가격 전략이 모두 경쟁 심화에 기여하고 있습니다. 재활센터와 병원은 종합적인 치료와 치료 서비스를 제공하는 데 중요한 역할을 합니다.

목차

제1장 뇌졸중 재활 시장 개요

  • 조사 범위
  • 시장 추정 연도

제2장 주요 요약

  • 시장 내역
  • 경쟁 인사이트

제3장 뇌졸중 재활 주요 시장 동향

  • 시장 성장 촉진요인
  • 시장 성장 억제요인
  • 시장 기회
  • 시장 전망 동향

제4장 뇌졸중 재활 산업 연구

  • PEST 분석
  • Porter's Five Forces 분석
  • 성장 전망 매핑
  • 규제 프레임워크 분석

제5장 뇌졸중 재활 시장 : 높아지는 지정학적 긴장의 영향

  • COVID-19 팬데믹의 영향
  • 러시아·우크라이나 전쟁의 영향
  • 중동 분쟁의 영향

제6장 뇌졸중 재활 시장 구도

  • 뇌졸중 재활 시장 점유율 분석(2024년)
  • 내역 데이터 : 주요 제조업체별
    • 기존 기업 분석
    • 신흥 기업 분석

제7장 뇌졸중 재활 시장 - 치료 유형별

  • 개요
    • 부문 점유율 분석 : 치료 유형별
    • 디바이스
    • 치료

제8장 뇌졸중 재활 시장 - 제품 유형별

  • 개요
    • 부문 점유율 분석 : 제품 유형별
    • 전기 자극기
      • 테이블톱
      • 웨어러블
    • 로봇 자극 장비
    • 무선 자극 장비
    • 비침습성 자극 장비
    • 인지 자극 장비
    • 기타 제품 유형

제9장 뇌졸중 재활 시장 - 뇌졸중 유형별

  • 개요
    • 부문 점유율 분석 : 뇌졸중 유형별
    • 허혈성 뇌졸중
    • 일과성 뇌허혈발작
    • 출혈성 뇌졸중

제10장 뇌졸중 재활 시장 - 최종 이용 업계별

  • 개요
    • 부문 점유율 분석 : 최종 이용 업계별
    • 병원
    • 외래 수술 센터
    • 장기 치료 센터
    • 전문 클리닉
    • 재택 케어 설정
    • 재활 센터
    • 기타 최종사용자 분야

제11장 뇌졸중 재활 시장 - 지역별

  • 소개
  • 북미
    • 개요
    • 북미의 주요 제조업체
    • 미국
    • 캐나다
  • 유럽
    • 개요
    • 유럽의 주요 제조업체
    • 독일
    • 영국
    • 프랑스
    • 이탈리아
    • 스페인
    • 네덜란드
    • 스웨덴
    • 러시아
    • 폴란드
    • 기타
  • 아시아태평양(APAC)
    • 개요
    • 아시아태평양의 주요 제조업체
    • 중국
    • 인도
    • 일본
    • 한국
    • 호주
    • 인도네시아
    • 태국
    • 필리핀
    • 기타
  • 라틴아메리카(LATAM)
    • 개요
    • 라틴아메리카의 주요 제조업체
    • 브라질
    • 멕시코
    • 아르헨티나
    • 콜롬비아
    • 기타
  • 중동 및 아프리카(MEA)
    • 개요
    • 중동 및 아프리카의 주요 제조업체
    • 사우디아라비아
    • 아랍에미리트
    • 이스라엘
    • 튀르키예
    • 알제리
    • 이집트
    • 기타

제12장 주요 벤더 분석 - 뇌졸중 재활 업계

  • 경쟁 벤치마킹
    • Competitive Dashboard
    • Competitive Positioning
  • 기업 개요
    • Penumbra, Inc.(REAL System)
    • Shanghai Siyi Intelligent Technology Co., Ltd.
    • DJO Global.
    • Saebo Inc
    • Shenzhen XFT Medical
    • Soterix Medical Inc.
    • Restorative Therapies
    • Zynex Medical, Inc
    • MYOLYN
    • ACP-Accelerated Care Plus
    • Neurosoft
    • BIONIK Inc
    • EB Neuro SpA
    • Motorika Medical
    • Ottobock
    • Guangzhou Longest Science &Technology Co., Ltd.
    • Roceso Technologies Pte Ltd
    • Brain Stimulation AB.
    • 기타

제13장 애널리스트의 전방위적 전망

KSM 25.10.30

Stroke Rehabilitation Market size was valued at US$ 289.39 Million in 2024, expanding at a CAGR of 11.60% from 2025 to 2032.

Rehabilitation is a service that assists patients with illness or injury in recovering and resuming their normal activities. Stroke rehabilitation restores independence by improving physical, mental, and emotional functions, such as movement, speech, strength, and daily activities. The type of treatment provided is determined by the affected areas of the brain. Stroke rehabilitation involves a variety of approaches, including motor-skill exercises, mobility training, and psychological assessment and treatment. Stroke rehabilitation services can be provided in a variety of settings, including inpatient, outpatient, skilled nursing facilities, and home-based rehabilitation.

Stroke Rehabilitation Market- Market Dynamics

Rising Incidence of Chronic Diseases Fuels Growth in the Stroke Rehabilitation Market

The increasing prevalence of chronic diseases is expected to drive the stroke rehabilitation market. Chronic diseases, which last a year or more and impair daily activities, require ongoing medical care. Stroke rehabilitation helps patients suffering from various chronic diseases, such as cardiovascular disease, by providing targeted care and support via therapy and assistive devices. For instance, the American College of Cardiology predicts that cardiovascular disease rates in the United States will rise significantly, including an increase in stroke cases. The rising prevalence of these diseases highlights the critical need for effective stroke rehabilitation services, which is driving market growth by increasing demand for therapies and devices that improve patient outcomes and quality of life.

Stroke Rehabilitation Market- Key Insights

Our research analyst estimates that the global market will grow at a CAGR of approximately 11.60% between 2025 and 2032.

In 2025, Therapy is expected to have the highest market share based on treatment type segmentation.

In 2025, hemorrhagic stroke is the most prevalent stroke type.

In 2025, hospitals are the leading end-user vertical segment for strokes.

North America is projected to generate the most revenue in 2025.

Stroke Rehabilitation Market- Segmentation Analysis:

The Global Stroke Rehabilitation Market is segmented on the basis of Treatment Type, Product Type, Stroke Type, End-user Verticals, and Region.

The market is divided into three categories based on Stroke Type: Ischemic Stroke, Hemorrhagic Stroke, and Transient Ischemic Attack. The hemorrhagic stroke segment is expected to experience significant growth in the stroke rehabilitation market during the forecast period. A hemorrhagic stroke occurs when a blood vessel in the brain breaks and bleeds. The rising incidence of hemorrhagic stroke, combined with increased research and development activities, drives the segment's growth. Rehabilitation after a hemorrhagic stroke does not reverse brain damage, but it can help people achieve the best long-term results. A study found that rehabilitation may be more effective following a hemorrhagic stroke than after an ischemic stroke. As a result, novel treatment strategies are being developed to provide more advanced care.

The market is divided into seven categories based on End-user Verticals: Hospitals, Ambulatory Surgical Centers, Long Term Treatment Centers, Specialty Clinics, Home Care Settings, Rehabilitation Centers, and Other End User Verticals. The hospitals segment will dominate the global stroke rehabilitation market in 2025. Patients prefer hospitals for stroke rehabilitation due to the availability of advanced equipment, skilled professionals, and adequate capital investments. Hospitals follow strict regulatory guidelines to provide better patient care. Furthermore, hospitals participate in a variety of clinical trials that evaluate the safety and efficacy of novel treatments. This allows patients to benefit from these treatment regimens. As a result, the increasing number of clinical trials contributes to the segment's growth. As of January 2025, there are 416 active, non-recruiting, and recruiting clinical trials registered in clinicaltrials.gov for stroke rehabilitation interventions.

Stroke Rehabilitation Market- Geographical Insights

North America will account for the largest share of the stroke rehabilitation market in 2025. The market is being driven by the rising prevalence of stroke, the increased adoption of advanced technologies, and the growing geriatric population. The United States currently has 62 million people aged 65 and up, accounting for 18% of the total population. It is projected that by 2054, 23% of the total US population will be over the age of 65. It is estimated that approximately one million people in Canada have had a stroke. This increases the demand for stroke rehabilitation. Increased investments by governments and private organizations support stroke rehabilitation in North America.

Asia-Pacific is expected to grow at the fastest rate in the stroke rehabilitation market over the forecast period. The market is driven by rising stroke rates, favorable government policies, and increased investments. Rising awareness and disposable income fuel the market. Countries such as China, India, and Japan are leading the way in promoting stroke rehabilitation in Asia-Pacific.

Stroke Rehabilitation Market- Competitive Landscape:

The stroke rehabilitation market has a diverse competitive landscape, including large, established medical device companies, specialized rehabilitation centers, and smaller technology startups. Major players, including Penumbra, Inc. (REAL System), Shanghai Siyi Intelligent Technology Co., Ltd., DJO Global, and Saebo Inc., provide a diverse range of rehabilitation products, including assistive devices, therapeutic equipment, and software solutions. Product innovation, clinical outcomes, and pricing strategies all contribute to the intensity of competition. Rehabilitation centers and hospitals play an important role in providing comprehensive care and therapy services.

Recent Developments:

In August, 2024, AmLife International is celebrating its tenth anniversary by launching AmHope, a rehabilitation and regenerative center. To commemorate this milestone, the company is investing RM 1.4 million to establish AmHope, a rehabilitation and regenerative center dedicated to assisting seniors in overcoming the challenges of stroke and other physical health issues.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL STROKE REHABILITATION MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS

  • Penumbra, Inc. (REAL System)
  • Shanghai Siyi Intelligent Technology Co., Ltd.
  • DJO Global.
  • Saebo Inc
  • Shenzhen XFT Medical
  • Soterix Medical Inc.
  • Restorative Therapies
  • Zynex Medical, Inc
  • MYOLYN
  • ACP - Accelerated Care Plus
  • Neurosoft
  • BIONIK Inc
  • EB Neuro S.p.A
  • Motorika Medical
  • Ottobock
  • Guangzhou Longest Science & Technology Co., Ltd.
  • Roceso Technologies Pte Ltd
  • Brain Stimulation AB.
  • Others

GLOBAL STROKE REHABILITATION MARKET, BY TREATMENT TYPE- MARKET ANALYSIS, 2019 - 2032

  • Devices
  • Therapy

GLOBAL STROKE REHABILITATION MARKET, BY PRODUCT TYPE- MARKET ANALYSIS, 2019 - 2032

  • Electrical Stimulators
  • Table Top
  • Wearable
  • Robotic Stimulators
  • Wireless Stimulators
  • Non-Invasive Stimulators
  • Cognitive Stimulators
  • Other Product Types

GLOBAL STROKE REHABILITATION MARKET, BY STROKE TYPE- MARKET ANALYSIS, 2019 - 2032

  • Ischemic Stroke
  • Transient Ischemic Attack
  • Hemorrhagic Stroke

GLOBAL STROKE REHABILITATION MARKET, BY END-USER VERTICALS- MARKET ANALYSIS, 2019 - 2032

  • Hospitals
  • Ambulatory Surgical Centers
  • Long Term Treatment Centers
  • Specialty Clinics
  • Home Care Settings
  • Rehabilitation Centers
  • Other End User Verticals

GLOBAL STROKE REHABILITATION MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032

  • North America
  • U.S.
  • Canada
  • Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • The Netherlands
  • Sweden
  • Russia
  • Poland
  • Rest of Europe
  • Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Australia
  • Indonesia
  • Thailand
  • Philippines
  • Rest of APAC
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Rest of LATAM
  • The Middle East and Africa
  • Saudi Arabia
  • UAE
  • Israel
  • Turkey
  • Algeria
  • Egypt
  • Rest of MEA

Table of Contents

1. Stroke Rehabilitation Market Overview

  • 1.1. Study Scope
  • 1.2. Market Estimation Years

2. Executive Summary

  • 2.1. Market Snippet
    • 2.1.1. Stroke Rehabilitation Market Snippet by Treatment Type
    • 2.1.2. Stroke Rehabilitation Market Snippet by Product Type
    • 2.1.3. Stroke Rehabilitation Market Snippet by Stroke Type
    • 2.1.4. Stroke Rehabilitation Market Snippet by End-user Verticals
    • 2.1.5. Stroke Rehabilitation Market Snippet by Country
    • 2.1.6. Stroke Rehabilitation Market Snippet by Region
  • 2.2. Competitive Insights

3. Stroke Rehabilitation Key Market Trends

  • 3.1. Stroke Rehabilitation Market Drivers
    • 3.1.1. Impact Analysis of Market Drivers
  • 3.2. Stroke Rehabilitation Market Restraints
    • 3.2.1. Impact Analysis of Market Restraints
  • 3.3. Stroke Rehabilitation Market Opportunities
  • 3.4. Stroke Rehabilitation Market Future Trends

4. Stroke Rehabilitation Industry Study

  • 4.1. PEST Analysis
  • 4.2. Porter's Five Forces Analysis
  • 4.3. Growth Prospect Mapping
  • 4.4. Regulatory Framework Analysis

5. Stroke Rehabilitation Market: Impact of Escalating Geopolitical Tensions

  • 5.1. Impact of COVID-19 Pandemic
  • 5.2. Impact of Russia-Ukraine War
  • 5.3. Impact of Middle East Conflicts

6. Stroke Rehabilitation Market Landscape

  • 6.1. Stroke Rehabilitation Market Share Analysis, 2024
  • 6.2. Breakdown Data, by Key Manufacturer
    • 6.2.1. Established Players' Analysis
    • 6.2.2. Emerging Players' Analysis

7. Stroke Rehabilitation Market - By Treatment Type

  • 7.1. Overview
    • 7.1.1. Segment Share Analysis, By Treatment Type, 2024 & 2032 (%)
    • 7.1.2. Devices
    • 7.1.3. Therapy

8. Stroke Rehabilitation Market - By Product Type

  • 8.1. Overview
    • 8.1.1. Segment Share Analysis, By Product Type, 2024 & 2032 (%)
    • 8.1.2. Electrical Stimulators
      • 8.1.2.1. Table Top
      • 8.1.2.2. Wearable
    • 8.1.3. Robotic Stimulators
    • 8.1.4. Wireless Stimulators
    • 8.1.5. Non-Invasive Stimulators
    • 8.1.6. Cognitive Stimulators
    • 8.1.7. Other Product Types

9. Stroke Rehabilitation Market - By Stroke Type

  • 9.1. Overview
    • 9.1.1. Segment Share Analysis, By Stroke Type, 2024 & 2032 (%)
    • 9.1.2. Ischemic Stroke
    • 9.1.3. Transient Ischemic Attack
    • 9.1.4. Hemorrhagic Stroke

10. Stroke Rehabilitation Market - By End-user Verticals

  • 10.1. Overview
    • 10.1.1. Segment Share Analysis, By End-user Verticals, 2024 & 2032 (%)
    • 10.1.2. Hospitals
    • 10.1.3. Ambulatory Surgical Centers
    • 10.1.4. Long Term Treatment Centers
    • 10.1.5. Specialty Clinics
    • 10.1.6. Home Care Settings
    • 10.1.7. Rehabilitation Centers
    • 10.1.8. Other End User Verticals

11. Stroke Rehabilitation Market- By Geography

  • 11.1. Introduction
    • 11.1.1. Segment Share Analysis, By Geography, 2024 & 2032 (%)
  • 11.2. North America
    • 11.2.1. Overview
    • 11.2.2. Stroke Rehabilitation Key Manufacturers in North America
    • 11.2.3. North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.2.4. North America Market Size and Forecast, By Treatment Type, 2019 - 2032 (US$ Million)
    • 11.2.5. North America Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 11.2.6. North America Market Size and Forecast, By Stroke Type, 2019 - 2032 (US$ Million)
    • 11.2.7. North America Market Size and Forecast, By End-user Verticals, 2019 - 2032 (US$ Million)
    • 11.2.8. U.S.
      • 11.2.8.1. Overview
      • 11.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.2.8.3. U.S. Market Size and Forecast, By Treatment Type, 2019 - 2032 (US$ Million)
      • 11.2.8.4. U.S. Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.2.8.5. U.S. Market Size and Forecast, By Stroke Type, 2019 - 2032 (US$ Million)
      • 11.2.8.6. U.S. Market Size and Forecast, By End-user Verticals, 2019 - 2032 (US$ Million)
    • 11.2.9. Canada
      • 11.2.9.1. Overview
      • 11.2.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.2.9.3. Canada Market Size and Forecast, By Treatment Type, 2019 - 2032 (US$ Million)
      • 11.2.9.4. Canada Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.2.9.5. Canada Market Size and Forecast, By Stroke Type, 2019 - 2032 (US$ Million)
      • 11.2.9.6. Canada Market Size and Forecast, By End-user Verticals, 2019 - 2032 (US$ Million)
  • 11.3. Europe
    • 11.3.1. Overview
    • 11.3.2. Stroke Rehabilitation Key Manufacturers in Europe
    • 11.3.3. Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.3.4. Europe Market Size and Forecast, By Treatment Type, 2019 - 2032 (US$ Million)
    • 11.3.5. Europe Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 11.3.6. Europe Market Size and Forecast, By Stroke Type, 2019 - 2032 (US$ Million)
    • 11.3.7. Europe Market Size and Forecast, By End-user Verticals, 2019 - 2032 (US$ Million)
    • 11.3.8. Germany
      • 11.3.8.1. Overview
      • 11.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.8.3. Germany Market Size and Forecast, By Treatment Type, 2019 - 2032 (US$ Million)
      • 11.3.8.4. Germany Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.3.8.5. Germany Market Size and Forecast, By Stroke Type, 2019 - 2032 (US$ Million)
      • 11.3.8.6. Germany Market Size and Forecast, By End-user Verticals, 2019 - 2032 (US$ Million)
    • 11.3.9. UK
      • 11.3.9.1. Overview
      • 11.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.9.3. UK Market Size and Forecast, By Treatment Type, 2019 - 2032 (US$ Million)
      • 11.3.9.4. UK Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.3.9.5. UK Market Size and Forecast, By Stroke Type, 2019 - 2032 (US$ Million)
      • 11.3.9.6. UK Market Size and Forecast, By End-user Verticals, 2019 - 2032 (US$ Million)
    • 11.3.10. France
      • 11.3.10.1. Overview
      • 11.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.10.3. France Market Size and Forecast, By Treatment Type, 2019 - 2032 (US$ Million)
      • 11.3.10.4. France Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.3.10.5. France Market Size and Forecast, By Stroke Type, 2019 - 2032 (US$ Million)
      • 11.3.10.6. France Market Size and Forecast, By End-user Verticals, 2019 - 2032 (US$ Million)
    • 11.3.11. Italy
      • 11.3.11.1. Overview
      • 11.3.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.11.3. Italy Market Size and Forecast, By Treatment Type, 2019 - 2032 (US$ Million)
      • 11.3.11.4. Italy Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.3.11.5. Italy Market Size and Forecast, By Stroke Type, 2019 - 2032 (US$ Million)
      • 11.3.11.6. Italy Market Size and Forecast, By End-user Verticals, 2019 - 2032 (US$ Million)
    • 11.3.12. Spain
      • 11.3.12.1. Overview
      • 11.3.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.12.3. Spain Market Size and Forecast, By Treatment Type, 2019 - 2032 (US$ Million)
      • 11.3.12.4. Spain Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.3.12.5. Spain Market Size and Forecast, By Stroke Type, 2019 - 2032 (US$ Million)
      • 11.3.12.6. Spain Market Size and Forecast, By End-user Verticals, 2019 - 2032 (US$ Million)
    • 11.3.13. The Netherlands
      • 11.3.13.1. Overview
      • 11.3.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.13.3. The Netherlands Market Size and Forecast, By Treatment Type, 2019 - 2032 (US$ Million)
      • 11.3.13.4. The Netherlands Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.3.13.5. The Netherlands Market Size and Forecast, By Stroke Type, 2019 - 2032 (US$ Million)
      • 11.3.13.6. The Netherlands Market Size and Forecast, By End-user Verticals, 2019 - 2032 (US$ Million)
    • 11.3.14. Sweden
      • 11.3.14.1. Overview
      • 11.3.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.14.3. Sweden Market Size and Forecast, By Treatment Type, 2019 - 2032 (US$ Million)
      • 11.3.14.4. Sweden Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.3.14.5. Sweden Market Size and Forecast, By Stroke Type, 2019 - 2032 (US$ Million)
      • 11.3.14.6. Sweden Market Size and Forecast, By End-user Verticals, 2019 - 2032 (US$ Million)
    • 11.3.15. Russia
      • 11.3.15.1. Overview
      • 11.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.15.3. Russia Market Size and Forecast, By Treatment Type, 2019 - 2032 (US$ Million)
      • 11.3.15.4. Russia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.3.15.5. Russia Market Size and Forecast, By Stroke Type, 2019 - 2032 (US$ Million)
      • 11.3.15.6. Russia Market Size and Forecast, By End-user Verticals, 2019 - 2032 (US$ Million)
    • 11.3.16. Poland
      • 11.3.16.1. Overview
      • 11.3.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.16.3. Poland Market Size and Forecast, By Treatment Type, 2019 - 2032 (US$ Million)
      • 11.3.16.4. Poland Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.3.16.5. Poland Market Size and Forecast, By Stroke Type, 2019 - 2032 (US$ Million)
      • 11.3.16.6. Poland Market Size and Forecast, By End-user Verticals, 2019 - 2032 (US$ Million)
    • 11.3.17. Rest of Europe
      • 11.3.17.1. Overview
      • 11.3.17.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.17.3. Rest of the Europe Market Size and Forecast, By Treatment Type, 2019 - 2032 (US$ Million)
      • 11.3.17.4. Rest of the Europe Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.3.17.5. Rest of the Europe Market Size and Forecast, By Stroke Type, 2019 - 2032 (US$ Million)
      • 11.3.17.6. Rest of the Europe Market Size and Forecast, By End-user Verticals, 2019 - 2032 (US$ Million)
  • 11.4. Asia Pacific (APAC)
    • 11.4.1. Overview
    • 11.4.2. Stroke Rehabilitation Key Manufacturers in Asia Pacific
    • 11.4.3. APAC Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.4.4. APAC Market Size and Forecast, By Treatment Type, 2019 - 2032 (US$ Million)
    • 11.4.5. APAC Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 11.4.6. APAC Market Size and Forecast, By Stroke Type, 2019 - 2032 (US$ Million)
    • 11.4.7. APAC Market Size and Forecast, By End-user Verticals, 2019 - 2032 (US$ Million)
    • 11.4.8. China
      • 11.4.8.1. Overview
      • 11.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.8.3. China Market Size and Forecast, By Treatment Type, 2019 - 2032 (US$ Million)
      • 11.4.8.4. China Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.4.8.5. China Market Size and Forecast, By Stroke Type, 2019 - 2032 (US$ Million)
      • 11.4.8.6. China Market Size and Forecast, By End-user Verticals, 2019 - 2032 (US$ Million)
    • 11.4.9. India
      • 11.4.9.1. Overview
      • 11.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.9.3. India Market Size and Forecast, By Treatment Type, 2019 - 2032 (US$ Million)
      • 11.4.9.4. India Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.4.9.5. India Market Size and Forecast, By Stroke Type, 2019 - 2032 (US$ Million)
      • 11.4.9.6. India Market Size and Forecast, By End-user Verticals, 2019 - 2032 (US$ Million)
    • 11.4.10. Japan
      • 11.4.10.1. Overview
      • 11.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.10.3. Japan Market Size and Forecast, By Treatment Type, 2019 - 2032 (US$ Million)
      • 11.4.10.4. Japan Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.4.10.5. Japan Market Size and Forecast, By Stroke Type, 2019 - 2032 (US$ Million)
      • 11.4.10.6. Japan Market Size and Forecast, By End-user Verticals, 2019 - 2032 (US$ Million)
    • 11.4.11. South Korea
      • 11.4.11.1. Overview
      • 11.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.11.3. South Korea Market Size and Forecast, By Treatment Type, 2019 - 2032 (US$ Million)
      • 11.4.11.4. South Korea Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.4.11.5. South Korea Market Size and Forecast, By Stroke Type, 2019 - 2032 (US$ Million)
      • 11.4.11.6. South Korea Market Size and Forecast, By End-user Verticals, 2019 - 2032 (US$ Million)
    • 11.4.12. Australia
      • 11.4.12.1. Overview
      • 11.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.12.3. Australia Market Size and Forecast, By Treatment Type, 2019 - 2032 (US$ Million)
      • 11.4.12.4. Australia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.4.12.5. Australia Market Size and Forecast, By Stroke Type, 2019 - 2032 (US$ Million)
      • 11.4.12.6. Australia Market Size and Forecast, By End-user Verticals, 2019 - 2032 (US$ Million)
    • 11.4.13. Indonesia
      • 11.4.13.1. Overview
      • 11.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.13.3. Indonesia Market Size and Forecast, By Treatment Type, 2019 - 2032 (US$ Million)
      • 11.4.13.4. Indonesia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.4.13.5. Indonesia Market Size and Forecast, By Stroke Type, 2019 - 2032 (US$ Million)
      • 11.4.13.6. Indonesia Market Size and Forecast, By End-user Verticals, 2019 - 2032 (US$ Million)
    • 11.4.14. Thailand
      • 11.4.14.1. Overview
      • 11.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.14.3. Thailand Market Size and Forecast, By Treatment Type, 2019 - 2032 (US$ Million)
      • 11.4.14.4. Thailand Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.4.14.5. Thailand Market Size and Forecast, By Stroke Type, 2019 - 2032 (US$ Million)
      • 11.4.14.6. Thailand Market Size and Forecast, By End-user Verticals, 2019 - 2032 (US$ Million)
    • 11.4.15. Philippines
      • 11.4.15.1. Overview
      • 11.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.15.3. Philippines Market Size and Forecast, By Treatment Type, 2019 - 2032 (US$ Million)
      • 11.4.15.4. Philippines Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.4.15.5. Philippines Market Size and Forecast, By Stroke Type, 2019 - 2032 (US$ Million)
      • 11.4.15.6. Philippines Market Size and Forecast, By End-user Verticals, 2019 - 2032 (US$ Million)
    • 11.4.16. Rest of APAC
      • 11.4.16.1. Overview
      • 11.4.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.16.3. Rest of APAC Market Size and Forecast, By Treatment Type, 2019 - 2032 (US$ Million)
      • 11.4.16.4. Rest of APAC Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.4.16.5. Rest of APAC Market Size and Forecast, By Stroke Type, 2019 - 2032 (US$ Million)
      • 11.4.16.6. Rest of APAC Market Size and Forecast, By End-user Verticals, 2019 - 2032 (US$ Million)
  • 11.5. Latin America (LATAM)
    • 11.5.1. Overview
    • 11.5.2. Stroke Rehabilitation Key Manufacturers in Latin America
    • 11.5.3. LATAM Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.5.4. LATAM Market Size and Forecast, By Treatment Type, 2019 - 2032 (US$ Million)
    • 11.5.5. LATAM Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 11.5.6. LATAM Market Size and Forecast, By Stroke Type, 2019 - 2032 (US$ Million)
    • 11.5.7. LATAM Market Size and Forecast, By End-user Verticals, 2019 - 2032 (US$ Million)
    • 11.5.8. Brazil
      • 11.5.8.1. Overview
      • 11.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.8.3. Brazil Market Size and Forecast, By Treatment Type, 2019 - 2032 (US$ Million)
      • 11.5.8.4. Brazil Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.5.8.5. Brazil Market Size and Forecast, By Stroke Type, 2019 - 2032 (US$ Million)
      • 11.5.8.6. Brazil Market Size and Forecast, By End-user Verticals, 2019 - 2032 (US$ Million)
    • 11.5.9. Mexico
      • 11.5.9.1. Overview
      • 11.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.9.3. Mexico Market Size and Forecast, By Treatment Type, 2019 - 2032 (US$ Million)
      • 11.5.9.4. Mexico Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.5.9.5. Mexico Market Size and Forecast, By Stroke Type, 2019 - 2032 (US$ Million)
      • 11.5.9.6. Mexico Market Size and Forecast, By End-user Verticals, 2019 - 2032 (US$ Million)
    • 11.5.10. Argentina
      • 11.5.10.1. Overview
      • 11.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.10.3. Argentina Market Size and Forecast, By Treatment Type, 2019 - 2032 (US$ Million)
      • 11.5.10.4. Argentina Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.5.10.5. Argentina Market Size and Forecast, By Stroke Type, 2019 - 2032 (US$ Million)
      • 11.5.10.6. Argentina Market Size and Forecast, By End-user Verticals, 2019 - 2032 (US$ Million)
    • 11.5.11. Colombia
      • 11.5.11.1. Overview
      • 11.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.11.3. Colombia Market Size and Forecast, By Treatment Type, 2019 - 2032 (US$ Million)
      • 11.5.11.4. Colombia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.5.11.5. Colombia Market Size and Forecast, By Stroke Type, 2019 - 2032 (US$ Million)
      • 11.5.11.6. Colombia Market Size and Forecast, By End-user Verticals, 2019 - 2032 (US$ Million)
    • 11.5.12. Rest of LATAM
      • 11.5.12.1. Overview
      • 11.5.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.12.3. Rest of LATAM Market Size and Forecast, By Treatment Type, 2019 - 2032 (US$ Million)
      • 11.5.12.4. Rest of LATAM Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.5.12.5. Rest of LATAM Market Size and Forecast, By Stroke Type, 2019 - 2032 (US$ Million)
      • 11.5.12.6. Rest of LATAM Market Size and Forecast, By End-user Verticals, 2019 - 2032 (US$ Million)
  • 11.6. Middle East and Africa (MEA)
    • 11.6.1. Overview
    • 11.6.2. Stroke Rehabilitation Key Manufacturers in Middle East and Africa
    • 11.6.3. MEA Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.6.4. MEA Market Size and Forecast, By Treatment Type, 2019 - 2032 (US$ Million)
    • 11.6.5. MEA Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 11.6.6. MEA Market Size and Forecast, By Stroke Type, 2019 - 2032 (US$ Million)
    • 11.6.7. MEA Market Size and Forecast, By End-user Verticals, 2019 - 2032 (US$ Million)
    • 11.6.8. Saudi Arabia
      • 11.6.8.1. Overview
      • 11.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.8.3. Saudi Arabia Market Size and Forecast, By Treatment Type, 2019 - 2032 (US$ Million)
      • 11.6.8.4. Saudi Arabia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.6.8.5. Saudi Arabia Market Size and Forecast, By Stroke Type, 2019 - 2032 (US$ Million)
      • 11.6.8.6. Saudi Arabia Market Size and Forecast, By End-user Verticals, 2019 - 2032 (US$ Million)
    • 11.6.9. United Arab Emirates
      • 11.6.9.1. Overview
      • 11.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.9.3. United Arab Emirates Market Size and Forecast, By Treatment Type, 2019 - 2032 (US$ Million)
      • 11.6.9.4. United Arab Emirates Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.6.9.5. United Arab Emirates Market Size and Forecast, By Stroke Type, 2019 - 2032 (US$ Million)
      • 11.6.9.6. United Arab Emirates Market Size and Forecast, By End-user Verticals, 2019 - 2032 (US$ Million)
    • 11.6.10. Israel
      • 11.6.10.1. Overview
      • 11.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.10.3. Israel Market Size and Forecast, By Treatment Type, 2019 - 2032 (US$ Million)
      • 11.6.10.4. Israel Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.6.10.5. Israel Market Size and Forecast, By Stroke Type, 2019 - 2032 (US$ Million)
      • 11.6.10.6. Israel Market Size and Forecast, By End-user Verticals, 2019 - 2032 (US$ Million)
    • 11.6.11. Turkey
      • 11.6.11.1. Overview
      • 11.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.11.3. Turkey Market Size and Forecast, By Treatment Type, 2019 - 2032 (US$ Million)
      • 11.6.11.4. Turkey Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.6.11.5. Turkey Market Size and Forecast, By Stroke Type, 2019 - 2032 (US$ Million)
      • 11.6.11.6. Turkey Market Size and Forecast, By End-user Verticals, 2019 - 2032 (US$ Million)
    • 11.6.12. Algeria
      • 11.6.12.1. Overview
      • 11.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.12.3. Algeria Market Size and Forecast, By Treatment Type, 2019 - 2032 (US$ Million)
      • 11.6.12.4. Algeria Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.6.12.5. Algeria Market Size and Forecast, By Stroke Type, 2019 - 2032 (US$ Million)
      • 11.6.12.6. Algeria Market Size and Forecast, By End-user Verticals, 2019 - 2032 (US$ Million)
    • 11.6.13. Egypt
      • 11.6.13.1. Overview
      • 11.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.13.3. Egypt Market Size and Forecast, By Treatment Type, 2019 - 2032 (US$ Million)
      • 11.6.13.4. Egypt Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.6.13.5. Egypt Market Size and Forecast, By Stroke Type, 2019 - 2032 (US$ Million)
      • 11.6.13.6. Egypt Market Size and Forecast, By End-user Verticals, 2019 - 2032 (US$ Million)
    • 11.6.14. Rest of MEA
      • 11.6.14.1. Overview
      • 11.6.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.14.3. Rest of MEA Market Size and Forecast, By Treatment Type, 2019 - 2032 (US$ Million)
      • 11.6.14.4. Rest of MEA Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.6.14.5. Rest of MEA Market Size and Forecast, By Stroke Type, 2019 - 2032 (US$ Million)
      • 11.6.14.6. Rest of MEA Market Size and Forecast, By End-user Verticals, 2019 - 2032 (US$ Million)

12. Key Vendor Analysis- Stroke Rehabilitation Industry

  • 12.1. Competitive Benchmarking
    • 12.1.1. Competitive Dashboard
    • 12.1.2. Competitive Positioning
  • 12.2. Company Profiles
    • 12.2.1. Penumbra, Inc. (REAL System)
    • 12.2.2. Shanghai Siyi Intelligent Technology Co., Ltd.
    • 12.2.3. DJO Global.
    • 12.2.4. Saebo Inc
    • 12.2.5. Shenzhen XFT Medical
    • 12.2.6. Soterix Medical Inc.
    • 12.2.7. Restorative Therapies
    • 12.2.8. Zynex Medical, Inc
    • 12.2.9. MYOLYN
    • 12.2.10. ACP - Accelerated Care Plus
    • 12.2.11. Neurosoft
    • 12.2.12. BIONIK Inc
    • 12.2.13. EB Neuro S.p.A
    • 12.2.14. Motorika Medical
    • 12.2.15. Ottobock
    • 12.2.16. Guangzhou Longest Science & Technology Co., Ltd.
    • 12.2.17. Roceso Technologies Pte Ltd
    • 12.2.18. Brain Stimulation AB.
    • 12.2.19. Others

13. 360 Degree AnalystView

14. Appendix

  • 14.1. Research Methodology
  • 14.2. References
  • 14.3. Abbreviations
  • 14.4. Disclaimer
  • 14.5. Contact Us
샘플 요청 목록
0 건의 상품을 선택 중
목록 보기
전체삭제